COVID-19: Warp Speed vaccines

被引：5
|
作者：
Feraoun, Yanis [1 ]
Maisonnasse, Pauline [1 ]
Le Grand, Roger [1 ]
Beignon, Anne-Sophie [1 ]
机构：
[1] Univ Paris Saclay, Dept IDMIT Infect Dis Models & Innovat Therapies, CEA,UMR 1184,Unite Inserm 1184, Immunol Malad Virales Autoimmunes Hematol & Bacte, 18 Route Panorama, F-92265 Fontenay Aux Roses, France
来源：
M S-MEDECINE SCIENCES | 2021年 / 37卷 / 8-9期
关键词：
NCOV-19; AZD1222; VACCINE; SARS-COV-2; INFECTION; EFFICACY; MEMORY; IMMUNOGENICITY; BNT162B2; HEALTH; PHASE-1; WORKERS; SAFETY;
D O I：
10.1051/medsci/2021094
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
A vaccine is required to effectively control the COVID-19 pandemic in the mid and long term. The development of vaccines against SARS-CoV-2 was initiated as soon as the genetic sequence of the virus was published, and has evolved at an unprecedented speed, with a first clinical trial launched in March 2020. One year later, more than a dozen of vaccines based on different concepts, with some having been evaluated only in clinical trials so far, are authorized under emergency procedures. Here, we review these vaccines, compare their properties and discuss the challenges they face, including the emergence of viral variants of concern.
引用
收藏
页码：759 / 772
页数：14
相关论文
共 50 条
  • [41] Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review
    Galmiche, Simon
    Nguyen, Liem Binh Luong
    Tartour, Eric
    de Lamballerie, Xavier
    Wittkop, Linda
    Loubet, Paul
    Launay, Odile
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (02) : 163 - 177
  • [42] Recent Update of COVID-19 Vaccines
    Jadaan, Sameer A.
    Khan, Abdul Waheed
    ADVANCED PHARMACEUTICAL BULLETIN, 2022, 12 (02) : 219 - 236
  • [43] COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics
    Amawi, Haneen
    Abu Deiab, Ghina'a I.
    Aljabali, Alaa A. A.
    Dua, Kamal
    Tambuwala, Murtaza M.
    THERAPEUTIC DELIVERY, 2020, 11 (04) : 245 - 268
  • [44] Vaccine versus Variants (3Vs): Are the COVID-19 Vaccines Effective against the Variants? A Systematic Review
    Hayawi, Kadhim
    Shahriar, Sakib
    Serhani, Mohamed Adel
    Alashwal, Hany
    Masud, Mohammad M.
    VACCINES, 2021, 9 (11)
  • [45] Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study
    Raethke, Monika
    van Hunsel, Florence
    Luxi, Nicoletta
    Lieber, Thomas
    Bellitto, Chiara
    Mulder, Erik
    Ciccimarra, Francesco
    Riefolo, Fabio
    Thurin, Nicolas H.
    Roy, Debabrata
    Morton, Kathryn
    Villalobos, Felipe
    Marques, Francisco Batel
    Farcas, Andreea
    Sonderlichova, Simona
    Belitser, Svetlana
    Klungel, Olaf
    Trifiro, Gianluca
    Sturkenboom, Miriam C.
    VACCINE, 2024, 42 (09) : 2357 - 2369
  • [46] Vaccines for COVID-19: Where do we stand in 2021?
    Sharma, Ketaki
    Koirala, Archana
    Nicolopoulos, Katrina
    Chiu, Clayton
    Wood, Nicholas
    Britton, Philip N.
    PAEDIATRIC RESPIRATORY REVIEWS, 2021, 39 : 22 - 31
  • [47] Adverse events and preventive measures related to COVID-19 vaccines
    Ahn, Tae Kyu
    Kang, Soo
    Paik, Jin Hui
    Seo, Young Ho
    CLINICAL AND EXPERIMENTAL EMERGENCY MEDICINE, 2021, 8 (03): : 153 - 159
  • [48] Safety, efficacy, and immunogenicity of COVID-19 vaccines; a systematic review
    Asghar, Neelam
    Mumtaz, Hassan
    Syed, Abdul Ahad
    Eqbal, Farea
    Maharjan, Reeju
    Bamboria, Aditya
    Shrehta, Manish
    IMMUNOLOGICAL MEDICINE, 2022, 45 (04) : 225 - 237
  • [49] Science at Warp Speed: Medical Research, Publication, and Translation During the COVID-19 Pandemic
    Lipworth, Wendy
    Gentgall, Melanie
    Kerridge, Ian
    Stewart, Cameron
    JOURNAL OF BIOETHICAL INQUIRY, 2020, 17 (04) : 555 - 561
  • [50] Immune response of COVID-19 vaccines in solid cancer patients: A meta-analysis
    Hua, Tiantian
    Fan, Ru
    Fan, Yang
    Chen, Feng
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
12345